期刊文献+

中国香港与中国内地中药注册分类及技术性申报资料要求的对比 被引量:1

Comparison of registration classification and technical application materials between Hong Kong and mainland of China
原文传递
导出
摘要 中药新药的注册申报涉及多种情况,其中中药经典名方、中药注射剂、中西药复方制剂等方面均为注册申报或中药监管所关注的热点或难点。重点比较了中国香港特别行政区中成药注册中固有药类别(古方)与中国内地经典名方(目前属于中药新药注册分类6.1类)注册申报的技术性资料要求的异同,同时对中药注射剂和中西药复方制剂不同的注册分类情况进行了对比。 The registration and application of new traditional Chinese medicine(TCM) involves a variety of situations, among which the TCM classical prescription, Chinese medicine injection, Chinese and western medicine compound preparation and other aspects are all the hot spots or difficulties in the registration and application or the supervision of TCM. This paper focuses on the comparison of the technical data requirements of the registration and application of the established medicines category(ancient prescription) in Hong Kong and the classic prescription in mainland of China(currently belonging to the new drug registration category 6.1 of TCM). At the same time, the registration classification of TCM injection and Chinese and western medicine compound preparation was compared.
作者 孙昱 SUN Yu(Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China)
出处 《药物评价研究》 CAS 2019年第8期1503-1508,共6页 Drug Evaluation Research
关键词 中药注册 古方 经典名方 中药注射剂 中西药复方制剂 registration of traditional Chinese medicine ancient prescription classical prescription Chinese medicine injection Chinese and western medicine compound preparation
  • 相关文献

同被引文献16

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部